These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1998789)

  • 1. Hormone replacement therapy and survival after surgery for ovarian cancer.
    Eeles RA; Tan S; Wiltshaw E; Fryatt I; A'Hern RP; Shepherd JH; Harmer CL; Blake PR; Chilvers CE
    BMJ; 1991 Feb; 302(6771):259-62. PubMed ID: 1998789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China.
    Wen Y; Huang H; Huang H; Wu M; Shen K; Pan L
    Climacteric; 2013 Dec; 16(6):673-81. PubMed ID: 23710587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis.
    Li D; Ding CY; Qiu LH
    Gynecol Oncol; 2015 Nov; 139(2):355-62. PubMed ID: 26232517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival.
    Ursic-Vrscaj M; Bebar S; Zakelj MP
    Menopause; 2001; 8(1):70-5. PubMed ID: 11201519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy.
    Johansen N; Liavaag AH; Iversen OE; Dørum A; Braaten T; Michelsen TM
    Acta Obstet Gynecol Scand; 2017 May; 96(5):547-555. PubMed ID: 28236297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study.
    Vermeulen RFM; Beurden MV; Kieffer JM; Bleiker EMA; Valdimarsdottir HB; Massuger LFAG; Mourits MJE; Gaarenstroom KN; van Dorst EBL; van der Putten HWHM; Aaronson NK
    Eur J Cancer; 2017 Oct; 84():159-167. PubMed ID: 28818705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone Use After Nonserous Epithelial Ovarian Cancer: Overall and Disease-Free Survival.
    Power L; Lefas G; Lambert P; Kim D; Evaniuk D; Lotocki R; Dean E; Nachtigal MW; Altman AD
    Obstet Gynecol; 2016 May; 127(5):837-847. PubMed ID: 27054933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
    Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
    J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer.
    Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Aiduk C
    Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less extensive surgery compared to extensive surgery: survival seems similar in young women with adult ovarian granulosa cell tumor.
    Lauszus FF; Petersen AC; Neumann G; Cleemann L; Rosgaard A; Jørgensen A; Vandborg M; Jakobsen A
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():61-6. PubMed ID: 24698496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone therapy and ovarian cancer.
    Mørch LS; Løkkegaard E; Andreasen AH; Krüger-Kjaer S; Lidegaard O
    JAMA; 2009 Jul; 302(3):298-305. PubMed ID: 19602689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen replacement therapy for ovarian carcinoma survivors: A randomized controlled trial.
    Guidozzi F; Daponte A
    Cancer; 1999 Sep; 86(6):1013-8. PubMed ID: 10491528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial.
    Eeles RA; Morden JP; Gore M; Mansi J; Glees J; Wenczl M; Williams C; Kitchener H; Osborne R; Guthrie D; Harper P; Bliss JM
    J Clin Oncol; 2015 Dec; 33(35):4138-44. PubMed ID: 26417001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
    Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
    BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premature menopause increases cardiovascular risk.
    Archer DF
    Climacteric; 2009; 12 Suppl 1():26-31. PubMed ID: 19811237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and prognosis in ovarian cancer patients.
    Hein A; Thiel FC; Bayer CM; Fasching PA; Häberle L; Lux MP; Renner SP; Jud SM; Schrauder MG; Müller A; Wachter D; Strehl J; Hartmann A; Beckmann MW; Rauh C
    Eur J Cancer Prev; 2013 Jan; 22(1):52-8. PubMed ID: 22694828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis.
    Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K
    Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
    Metcalfe K; Lynch HT; Foulkes WD; Tung N; Kim-Sing C; Olopade OI; Eisen A; Rosen B; Snyder C; Gershman S; Sun P; Narod SA
    JAMA Oncol; 2015 Jun; 1(3):306-13. PubMed ID: 26181175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.